Revolutionizing drug discovery with SmartCADD

FHS
October 8, 2024
10:58 am

Drug discovery is much like working a jigsaw puzzle. The chemical compounds behind drug molecules must be shaped to fit with the proteins in our bodies to produce therapeutic effects.

IGC Pharma heads towards a Phase I study for Alzheimer’s disease – Pharmaceutical Technology

Share this article TGR-63, being developed to target amyloid-beta plaques, has shown preclinical potential in reducing Alzheimer’s-related anxiety. Credits: AtlasStudio/Shutterstock.com With positive preclinical data for

February 2, 2024

Tampa General Hospital Deploys AI to Optimize Surgical Ops

What You Should Know: – Tampa General Hospital (TGH) announced the implementation of Apella, an advanced AI-powered platform designed to enhance operating room efficiency and

August 9, 2024

Opinion | Our Patients With Disabilities Face Unique Environmental Risks

Lowe Taylor is a physiatrist. In 2018, I was a young medical resident working on a spinal cord injury unit at the Palo Alto Veterans

September 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.